Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

Nat Rev Immunol. 2012 Oct;12(10):740; author reply 740. doi: 10.1038/nri3192-c1. Epub 2012 Aug 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Clinical Trials as Topic*
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal, Humanized